JUMPSTART-ANAI for Advance Care Planning
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to enhance how Alaska Native and American Indian adults with serious illnesses plan their future healthcare. It compares usual care with a special communication tool called JUMPSTART-ANAI, which helps patients discuss their healthcare wishes with their doctors. The trial seeks participants who are at least 40 years old, have a serious illness like cancer or COPD, and have visited their primary care doctor at least twice in the past year. Participants should not already have an advance directive, which is a document outlining a person's healthcare preferences. As an unphased trial, this study offers a unique opportunity to contribute to improving healthcare communication for future patients.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the JUMPSTART-ANAI intervention is safe for advance care planning?
Research has shown that JUMPSTART-ANAI is a tool designed to initiate conversations about advance care planning (ACP) while respecting cultural differences. No evidence has indicated any negative effects from using this tool. This study does not test a new drug or medical treatment, so the risks differ from those in studies involving experimental medicines. Instead, it seeks to enhance discussions about medical care preferences, which is generally safe. Without traditional side effects, it is considered a low-risk option for participants.12345
Why are researchers excited about this trial?
Researchers are excited about JUMPSTART-ANAI because it tackles advance care planning in a fresh, interactive way. Unlike traditional methods that might involve static discussions or standard directives, JUMPSTART-ANAI includes questionnaires designed to dive into personal experiences, preferences, and concerns. This approach not only engages patients more actively but also provides feedback for both patients and providers, potentially leading to more personalized and effective care planning. By focusing on these dynamic interactions, JUMPSTART-ANAI aims to enhance communication and understanding in advance care planning, paving the way for better patient-centered outcomes.
What evidence suggests that the JUMPSTART-ANAI intervention is effective for advance care planning in the ANAI population?
Research has shown that advance care planning (ACP) activities, such as JUMPSTART-ANAI, increase discussions and documentation about future medical care among patients. These activities ensure healthcare aligns with patients' preferences and values. Although some studies have shown mixed results, the general trend suggests ACP improves communication between patients and healthcare providers. In this trial, participants may receive either the Jumpstart 1 or Jumpstart 2 intervention, both tailored to the cultural needs of Alaska Native and American Indian communities, potentially enhancing the planning's effectiveness. By encouraging these discussions, JUMPSTART-ANAI aims to better meet the healthcare needs of older adults in these communities.12367
Who Is on the Research Team?
Jennifer Shaw, PhD
Principal Investigator
University of Alaska Fairbanks
Are You a Good Fit for This Trial?
This trial is for older Alaska Native/American Indian adults with serious illnesses who have not yet engaged in advance care planning. It aims to help ensure their medical care aligns with personal values and preferences.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the JUMPSTART-ANAI intervention, a culturally tailored ACP communication intervention
Follow-up
Participants are monitored for the presence of an advance directive in the electronic health record
What Are the Treatments Tested in This Trial?
Interventions
- JUMPSTART-ANAI
Find a Clinic Near You
Who Is Running the Clinical Trial?
Southcentral Foundation
Lead Sponsor
University of Arkansas
Collaborator
University of Washington
Collaborator
University of Colorado, Denver
Collaborator
Alaska Native Tribal Health Consortium
Collaborator
University of Alaska Fairbanks
Collaborator